PLXDC2 and cancer: Interestingly, another PEDF receptor, PLXDC2 was found to be expressed in a variety of cancers, including colon cancer, hepatocellular carcinoma, laryngeal cancer, testicular seminoma, and vulva squamous cell carcinoma [24–28].